MVs released from CD105+ RCC cells promoted in vitro and in vivo tumor angiogenesis – probably by carrying pro-angiogenic mRNAs and miRNAs that were absent in those derived from CD105− differentiated tumor cells. This evidence concerns the gene ENG and renal cell carcinoma.